Global High-Performance Liquid Chromatography Market

High-Performance Liquid Chromatography Market Size, Share, Growth Analysis, By Product(Instruments, HPLC Systems, Pumps, Detectors), By Application(Clinical Research Applications, Diagnostic Applications, Forensic Applications, Other Applications), By End - User(Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2193 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 105 | Figures: 66

High-Performance Liquid Chromatography Market Insights

Global High-Performance Liquid Chromatography Market size was valued at USD 4.77 billion in 2022 and is poised to grow from USD 5.06 billion in 2023 to USD 8.06 billion by 2030, growing at a CAGR of 6% in the forecast period (2024-2031).

The market is projected to expand owing to advancements in high-performance liquid chromatography (HPLC) techniques, elevating the reliability and robustness of liquid chromatography operations. Notably, recent HPLC systems offer enhanced features like dual-injection mechanisms, multidimensional capabilities, and intermediate pressure alternatives, bolstering their applicability across diverse research domains. The COVID-19 pandemic has additionally expedited the adoption of HPLC systems, instrumental in developing novel therapeutics, vaccines, and dependable diagnostic techniques for the virus. A case in point is a study published in October 2021 in the Microchemical Journal, unveiling an innovative HPLC-based method for analyzing favipiravir, an emerging antiviral for COVID-19.

Furthermore, considering the mounting apprehensions regarding SARS-CoV-2 mutations, HPLC's epidemiological applications in characterizing viral proteins linked to emerging viral serotypes are poised to gain traction, further boosting market expansion.

Moreover, the recent introduction of various liquid chromatography method development systems and accompanying software is anticipated to simplify usage and heighten HPLC system productivity. A notable instance is the collaboration between Thermo Fisher Scientific, Inc. and ChromSword, resulting in the Thermo Fisher Vanquish HPLC and UHPLC method development system unveiled in August 2021. Likewise, in April 2022, Shimadzu Corporation launched the LabSolutions MD software, specifically designed for HPLC platforms to facilitate analytical method development. These product launches are poised to augment the market presence of HPLC systems and propel market expansion.

US High-Performance Liquid Chromatography Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

High-Performance Liquid Chromatography Market size was valued at USD 4.77 billion in 2022 and is poised to grow from USD 5.06 billion in 2023 to USD 8.06 billion by 2030, growing at a CAGR of 6% in the forecast period (2024-2031).

The competitive landscape of the High-Performance Liquid Chromatography (HPLC) market is characterized by intense rivalry among prominent players, driven by the increasing demand for accurate and advanced analytical solutions. Established manufacturers and emerging entrants compete to secure market share by offering innovative HPLC systems, columns, detectors, and software platforms. 'Agilent Technologies, Inc. (USA)', 'Thermo Fisher Scientific, Inc. (USA)', 'Shimadzu Corporation (Japan)', 'Waters Corporation (USA)', 'PerkinElmer, Inc. (USA)', 'Bruker Corporation (USA)', 'Bio-Rad Laboratories, Inc. (USA)', 'JASCO Corporation (Japan)', 'Gilson, Inc. (USA)', 'Knauer GmbH (Germany)'

The pharmaceutical and biopharmaceutical sectors' growth drives the demand for high-performance liquid chromatography (HPLC) systems for drug analysis, quality control, and research and development.

Hyphenated Techniques: The integration of HPLC with mass spectrometry (LC-MS) and other hyphenated technologies enhances analytical capabilities, providing more comprehensive information and improving sensitivity.

In the year 2021, North America held a commanding market share, surpassing 30.0%. This notable prevalence can be attributed to the dynamic expansion of the pharmaceutical industry, substantial investments directed towards research and development endeavors, an escalating demand for clinical diagnostic applications, and the strategic presence of industry leaders like Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., and Bio-Rad Laboratories, Inc. within this geographical sphere. Moreover, the region derives distinct advantages from its heightened scientific awareness and the availability of a skilled workforce, contributing to the escalated adoption and growth of HPLC applications.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global High-Performance Liquid Chromatography Market

Report ID: SQMIG35H2193

$5,300
BUY NOW GET FREE SAMPLE